MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical and epidemiological profile of Parkinson’s disease in India

A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma (Kochi, India)

Meeting: 2024 International Congress

Abstract Number: 449

Keywords: Environmental toxins, Parkinson’s, Synucleinopathies

Category: Epidemiology

Objective: To study the clinical profile and risk factors of Parkinson’s disease (PD) in India.

Background: The current knowledge of clinical and epidemiological profile of PD is from European-origin populations. A considerable knowledge gap exists regarding PD in the Indian population.

Method: A multi-institutional network of movement disorder specialists and neurologists from 18 tertiary-care hospitals across India recruited prospectively, PD patients of Asian- Indian origin. Controls were ethnicity-matched, healthy subjects from the same geographical areas. Uniform protocol, questionnaire and proforma were applied.1 Corrections were applied for multiple comparisons and P<0.007 was considered significant.

Results: 7918 cases and 6640 gender-matched controls were studied. In age and gender- adjusted comparisons, agricultural jobs, exposure to insecticides/pesticides and head injury carried increased risk for PD. Surprisingly, smoking and caffeine intake were not protective. Co-morbidities of diabetes, hypertension, hypercholesterolemia, coronary artery disease, anxiety, and depression were higher in cases. Stratification based on age of onset into EOPD (<50 years) and LOPD (>50 years), showed that age- at- study and disease duration were higher in LOPD. Similarly, risk exposures, co-morbidities  were more in LOPD and family history in EOPD. Rest tremor and non-motor symptoms (NMS) were more in LOPD. Motor fluctuations, dyskinesias, depression and cognitive scores were worse in EOPD. In gender-based comparisons, men were older, had more frequent family history, increased exposure to risk factors and co-morbidities.  Cognitive and depression scores were worse in women while other NMS were more in men. There was no difference in UPDRS I to III but motor fluctuations and dyskinesias were commoner in men. Finally, the motor phenotypes2 were predominantly postural instability gait disorder (PIGD=47.1%), followed by tremor-dominant (TD=33.3%), and indeterminate (IT =19.5%) types. Age at study, age at onset and disease duration were higher in PIGD than TD. Agricultural jobs and exposure to risk factors were more in PIGD. Scores of UPDRS I to IV, cognition and depression were worse and NMS was reported more in PIGD.

Conclusion: Our study is the first to provide a comprehensive assessment of PD in India which will be required for the practice of precision medicine for PD in India.

References: 1. Rajan R, Divya KP, Kandadai RM3, Yadav R, Satagopam VP, Madhusoodanan UK et al. Genetic architecture of Parkinson’s disease in the Indian population: harnessing
genetic diversity to address critical gaps in Parkinson’s disease research. Front in Neurol 2020; 11:1-11.
2. Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., et al. Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The
Parkinson Study Group. Neurology 1990;40: 1529–1534

To cite this abstract in AMA style:

A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma. Clinical and epidemiological profile of Parkinson’s disease in India [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-and-epidemiological-profile-of-parkinsons-disease-in-india/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-epidemiological-profile-of-parkinsons-disease-in-india/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley